Janssen-cilag Pty Ltd is a limited by shares Australian proprietary company. Located at NSW 2113 since 2014-09-24 the company is, as the updated on 2016-07-06 ABN database shows, registered. The company has been registered for Goods & Services Tax since 2000-07-01. Known company numbers for Janssen-cilag Pty Ltd are as follows: ACN - 000129975, Australian Business Number - 47000129975. Janssen-cilag Pty Ltd has been the company name since 2018-07-24. Johnson & Johnson Innovation is an example of a business name Janssen-cilag Pty Ltd used. The complete list includes 10 business names. Johnson & Johnson Innovation was the company's business name from 2016-07-06. Other business names include Tibotec (from 2008-04-24 to 2011-07-28) and Renal Anaemia Coordinators Program (from 2002-05-23 to 2005-08-25). Their official company name changed on 2000-05-09 to Janssen-cilag Pty Ltd. The company had used this name up until 2002-01-30. This Australian proprietary company was previously located in NSW 2113 (from 2014-03-26 to 2014-09-24), NSW 2113 (from 2014-01-11 to 2014-03-25), NSW 2113 (from 2000-05-09 to 2014-01-11). Aubiz
| Status | From | To |
|---|---|---|
| Active | Tue, 9th May 2000 | current |
| Name | From | To |
|---|---|---|
| Janssen-cilag Pty Ltd | Wed, 30th Jan 2002 | current |
| Janssen-cilag Pty Ltd | Tue, 9th May 2000 | Wed, 30th Jan 2002 |
| Name | From | To |
|---|---|---|
| Johnson & Johnson Innovation | Wed, 6th Jul 2016 | current |
| Tibotec | Thu, 24th Apr 2008 | Thu, 28th Jul 2011 |
| Renal Anaemia Coordinators Program | Thu, 23rd May 2002 | Thu, 25th Aug 2005 |
| Precious Time | Thu, 23rd May 2002 | Fri, 10th Oct 2014 |
| Nizoral | Tue, 9th May 2000 | Thu, 16th Jul 2009 |
| Vermox | Tue, 9th May 2000 | Wed, 9th May 2007 |
| Monistat | Tue, 9th May 2000 | Tue, 24th Jun 2003 |
| Imodium | Tue, 9th May 2000 | Sun, 8th Apr 2012 |
| Daktarin | Tue, 9th May 2000 | Thu, 16th Jul 2009 |
| Livostin | Tue, 9th May 2000 | Thu, 16th Jul 2009 |
| Location | From | To |
|---|---|---|
| NSW 2113 | Wed, 24th Sep 2014 | current |
| NSW 2113 | Wed, 26th Mar 2014 | Wed, 24th Sep 2014 |
| NSW 2113 | Sat, 11th Jan 2014 | Tue, 25th Mar 2014 |
| NSW 2113 | Tue, 9th May 2000 | Sat, 11th Jan 2014 |
| Status | From | To |
|---|---|---|
| Registered | Sat, 1st Jul 2000 | current |
Advertisements
| Application date: | Thu, 6th Jun 1996 |
| Lodgement date: | Thu, 6th Jun 1996 |
| Live or dead: | Dead |
| CPI status: | Never Registered |
| Status: | Lapsed/Not Protected |
| Mark code: | Trade Mark |
| Trademark type: | Composite |
| Acceptance due date: | Sat, 9th May 1998 |
| Court orders: | No |
| Revocation of the acceptance: | No |
| Goods and services assistance: | No |
| Lodgement type: | National |
| Descriptive: | Janesen - Cilag Communique |
| Device phrases: | Bird In Flight Carrying Letter |
| Examination report number: | 1 |
| Examination class count: | 1 |
| NICE class code: | 42 |
| NICE occ number: | 1 |
| NICE description text: | Communique Is A Customer Loyalty Program Offering Its Members Resources - Eg Journals, Clinical Trials And Information On Seminars, Conferences Etc. It Is Free Of Charge |
| Suburb name: | Lane Cove |
| Postcode: | 2066 |
| Australian state code: | NSW |
| Country code: | AU |
| Attorney code: | -70623 |
| Agency code: | SW |
| Transaction type: | Address for service of the trademark |
| Suburb name: | Sydney |
| Postcode: | 2000 |
| Australian state codee: | NSW |
| Attorney type: | Attorney |
| Country code: | AU |
Contains public sector information licensed under the Creative Commons Attribution 3.0 Australia licence. Material on this website was obtained from publicly-accessible databases and is attributed to ©Commonwealth of Australia 2024 (http://data.gov.au, http://acnc.gov.au/ and http://abr.business.gov.au/), ©Intellectual Property Government Open Data 2024, ©ASIC - Company Register. While we try to make the information as precise and up-to-date as possible, we are aware the datasets are not always error-free. Aubiz.net will not take responsibility for any errors in the databases. The material provided should be treated as a starting point of more in-depth research, not as fact.